Harel Insurance Investments & Financial Services’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
DG
NI
Harel Insurance Investments & Financial Services's HCAT Position: Q3 2024 in Review
Harel Insurance Investments & Financial Services sold out of Health Catalyst (HCAT) in Q3 2024, closing a stake of 268 shares — an estimated $2K sold.
Harel Insurance Investments & Financial Services first reported a position in HCAT in Q1 2021 and held it in 14 quarters. The position peaked at $783K in Q1 2021. 159 funds tracked by Wall St. Rank hold HCAT as of Q3 2024.
- Harel Insurance Investments & Financial Services reported no remaining Health Catalyst position as of Q3 2024 after selling out during the quarter.
- Harel Insurance Investments & Financial Services sold 268 Health Catalyst shares in Q3 2024, an estimated $2K.
- Harel Insurance Investments & Financial Services first reported a position in Health Catalyst in Q1 2021 and held it in 14 quarters.
- Harel Insurance Investments & Financial Services's Health Catalyst position peaked at $783K in Q1 2021.
- 159 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2024.
Based on Harel Insurance Investments & Financial Services's 13F filing for Q3 2024, filed 15 Oct 2024.